Vice President, Public Health Policy And Strategic Engagement, Biomerieux
Bruce Altevogt serves as Vice President of Public Health Policy and Strategic Engagement at bioMérieux, a leading global diagnostics company. In this role Dr. Altevogt focuses on establishing a regulatory and policy environment that nurtures the improved utilization of diagnostics solutions, unleashing their potential for transforming health. In addition, he serves as a board member of the AMR Industry Alliance Board.
Prior to joining bioMérieux, Dr. Altevogt held positions at Pfizer including Vice President and Head External Engagement where he was responsible for establishing and managing patient and medical stakeholder engagement and the above-brand AMR Medical strategy. Dr. Altevogt also served as Senior Director of Science Policy and Science Advocacy, where he managed policy issues in support of Pfizer’s research & development enterprise, vaccines, and led AMR policy. Dr. Altevogt also has 12 year’s experience at the not-for-profit National Academy of Sciences. While at the National Academies he oversaw the publication of over 50 reports and led policy initiatives related to basic research, drug discovery and development, and public health preparedness.
Dr. Altevogt received a doctorate from Harvard University’s Program in Neuroscience and a B.A. from the University of Virginia, where he majored in Biology and minored in South Asian Studies.
